Dong, M., Koole, C., Wootten, D., Sexton, P
To confirm the establishment of the disease state, statistical differences between normal CE-2-fed wild-type mice and vehicle-treated WD-fed MC4R-KO mice were analyzed using Students t-test
The intranasal GHK-Cu treatment was found to delay cognitive impairment, reduce amyloid plaques, and lower inflammation levels in the frontal cortex and hippocampus .37 Randomized controlled trials in human patients are needed to confirm the benefit of GHK-Cu for cognitive decline and Alzheimers disease as well as to evaluate safe and effective human dosing (the human dose equivalent of 15mg/kg in mice would be ~1.2mg/kg, though data on this or any other dosing nasally in humans is not currently available), but preliminary animal trials are promising
Why to Avoid: High sugar intake can lead to blood sugar spikes and crashes, increasing hunger and cravings and undermining the benefits of tirzepatide
10.1016/j.jss.2009.04.030 J
Third Party Lab Testing Peptides: Why It Matters third party lab testing peptides Why third-party testing matters and how to confirm a vendor actually does it
